Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specifi... CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -7.315 | -14.0013398411 | 52.245 | 55.88 | 44.02 | 3460244 | 50.78173833 | CS |
| 4 | 2.86 | 6.79819348705 | 42.07 | 55.88 | 38.28 | 2615993 | 45.91915304 | CS |
| 12 | -9.24 | -17.0574118516 | 54.17 | 55.88 | 36.52 | 2149200 | 44.24522834 | CS |
| 26 | -4.22 | -8.58596134283 | 49.15 | 59.0693 | 36.52 | 1671846 | 46.14208733 | CS |
| 52 | -38.57 | -46.1916167665 | 83.5 | 90.62 | 36.52 | 1507911 | 52.81180694 | CS |
| 156 | -12.58 | -21.8744566162 | 57.51 | 91.1 | 36.52 | 1528268 | 57.63503788 | CS |
| 260 | -7.6 | -14.4679230916 | 52.53 | 220.21 | 32 | 1473598 | 77.52882842 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
